Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 4, 2009, Pages 474-477

  Sabatini, Peter R ^a   Ducic, Yadranko ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LOCAL METASTASIS; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE; LYMPHADENOPATHY; MALE; MEDICAL SPECIALIST; NECK DISSECTION; OROPHARYNX CARCINOMA; PHYSICAL EXAMINATION; RADIATION DOSE; RETROSPECTIVE STUDY; SEROMA; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; SALVAGE THERAPY;

EID: 70349326285     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.06.749     Document Type: Article

References (11)

1. Pellitteri P.K., Ferlito A., Rinaldo A., et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?. Head Neck 28 (2006) 166-175
2. Brkovich V.S., Miller F.R., Karnad A.B., et al. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 116 (2006) 855-858
3. Yao M., Smith R.B., Graham M.M., et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 63 (2005) 991-999
4. Gourin C.G., Williams H.T., Seabolt W.N., et al. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 116 (2006) 705-710
5. Stenson K.M., Haraf D.J., Pelzer H., et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 126 (2000) 950-956
6. Grabenbauer G.G., Rodel C., Ernst-Stecken A., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only?. Radiother Oncol 66 (2003) 57-63
7. Brizel D.M., Prosnitz R.G., Hunter S., et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1418-1423
8. McHam S.A., Adelstein D.J., Rybicki L.A., et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?. Head Neck 25 (2003) 791-798
9. Sewall G.K., Palazzi-Churas K.L., Richards G.M., et al. Planned postradiotherapy neck dissection: Rationale and clinical outcomes. Laryngoscope 117 (2007) 121-128
10. Nouraei S.A., Upile T., Al-Yaghchi C., et al. Role of planned postchemoradiotherapy selective neck dissection in the multimodality management of head and neck cancer. Laryngoscope 118 (2008) 797-803
11. Yao M., Luo P., Hoffman H.T., et al. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clin Oncol 30 (2007) 264-270